Six More Clinical Trials Proposed For High Priority Status, But Per Case Funds For Them Not Assured
In Brief: Metcalf, Sachs, Nowell, Rowley, Elkind Win 1989 GM Award; Ray Morrison Retires
DCT Board Approves Recompetition f $4.3 Million CTEP Information System Contract
FDA Advisors Recommend Approval Of Leucovorin, Hexamethylmelamine
FDA, NCI Seek Compromise On Survival Endpoints
Trending Stories
- Before the Olympics were smoke-free, tobacco brand deals ran rampant
- Kamala Harris widely expected to continue Cancer Moonshot; Conservatives present their vision in Project 2025
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- ODAC vote will likely lead to three-arm and four-arm designs–and pragmatic trials–for perioperative indications
- Jonathan Gerber named chief clinical officer of NYU Langone Health’s Perlmutter Cancer Center
- Tweaking the existing systems is not the answer to drug shortages